Abstract:A series of novel 2-pyridyl, 4-morpholinyl substituted thiazolo[5,4-b]pyridine analogues have been designed and synthesized in this paper. These thiazolo[5,4-b]pyridines were efficiently prepared in seven steps from commercially available substances in moderate to good yields. All of these N-heterocyclic compounds were characterized by nuclear magnetic resonance (NMR) and high-resolution mass spectrometry (HRMS) analysis and tested for phosphoinositide 3-kinase (PI3K) enzymatic assay. The results indicated that these N-heterocyclic compounds showed potent PI3K inhibitory activity, and the IC50 of a representative compound (19a) could reach to 3.6 nm. The structure-activity relationships (SAR) study showed that sulfonamide functionality was important for PI3K alpha inhibitory activity, and 2-chloro-4-florophenyl sulfonamide (19b), or 5-chlorothiophene-2-sulfonamide (19c) showed potent inhibitory activity with a nanomolar IC50 value. The pyridyl attached to thiazolo[5,4-b]pyridine was another key structural unit for PI3K alpha inhibitory potency, and replacement by phenyl lead to a significant decrease in activity. Enzymatic Inhibition results showed that compound 19a inhibited PI3K alpha, PI3K gamma, or PI3K delta with a nanomolar IC50 value, but its inhibitory activity on PI3K beta was approximately 10-fold reduced. Further docking analysis revealed that the N-heterocyclic core of compound 19a was directly involved in the binding to the kinase through the key hydrogen bonds interaction.

Identification and Synthesis of Substituted Pyrrolo[2,3-D]pyrimidines As Novel Firefly Luciferase Inhibitors

Identification of 2-Benzylidene-tetralone Derivatives As Highly Potent and Reversible Firefly Luciferase Inhibitors.

Mechanism-based Design of a Photoactivatable Firefly Luciferase.

False positives in a reporter gene assay: identification and synthesis of substituted N-pyridin-2-ylbenzamides as competitive inhibitors of firefly luciferase.

Synthesis and biological evaluation of a series of aryl triazoles as firefly luciferase inhibitors

Discovery of a series of 2-phenylnaphthalenes as firefly luciferase inhibitors

Inhibiting Firefly Bioluminescence by Chalcones

Identification of Novel Thiazolo[5,4-<i>b</i>]Pyridine Derivatives as Potent Phosphoinositide 3-Kinase Inhibitors

Identification of novel inhibitors of Aurora A with a 3-(pyrrolopyridin-2-yl)indazole scaffold.

Cybluc: an Effective Aminoluciferin Derivative for Deep Bioluminescence Imaging

Novel Furimazine Derivatives for Nanoluciferase Bioluminescence with Various C-6 and C-8 Substituents

Discovery and Synthesis of a Novel Series of Potent, Selective Inhibitors of the PI3Kα: 2-Alkyl-chromeno[4,3-c]pyrazol-4(2h)-one Derivatives.

Design, Synthesis and Anti-Proliferative Activities of 2,6-Substituted Thieno[3,2-d]pyrimidine Derivatives Containing Electrophilic Warheads

Identification of 1, 4-Dihydrothieno[3 ', 2 ':5, 6] Thiopyrano [4, 3-C]pyrazole Derivatives As Human 5-Lipo-oxygenase Inhibitors

Design and Synthesis of a Pyrido[2,3-D]pyrimidin-5-one Class of Anti-Inflammatory FMS Inhibitors

Design, Synthesis and Biological Evaluation of 4-Aryl-5,7-dihydro-6h-pyrrolo[2,3-d]pyrimidin-6-one Derivatives As a PI3Kα Inhibitor.

Design, Synthesis and Biological Activity of 4-(4-benzyloxy)phenoxypiperidines As Selective and Reversible LSD1 Inhibitors.

Synthesis, pharmacophores, and mechanism study of pyridin-2(1H)-one derivatives as regulators of translation initiation factor 3A.

Design, Synthesis, and Biological Evaluation of Substituted Pyrimidines as Potential Phosphatidylinositol 3-Kinase (PI3K) Inhibitors

Identification of 4-(2-furanyl)pyrimidin-2-amines As Janus Kinase 2 Inhibitors.

Synthesis of pyrrolopyrimidines and their JAK3 inhibitory activities